Start Over

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx

Authors :: Machiels, Jean-Pascal
Leemans, René C
Golusinski, Wojciech
Grau, Cai
Licitra, Lisa
Gregoire, Vincent
EHNS Executive Board. Electronic address: secretariat@ehns.org
ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
ESTRO Executive Board. Electronic address: info@estro.org
Otolaryngology / Head & Neck Surgery
AII - Cancer immunology
CCA - Cancer biology and immunology
CCA - Cancer Treatment and quality of life
UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
UCL - (SLuc) Centre du cancer
UCL - (SLuc) Unité d'oncologie médicale
UCL - (SLuc) Service d'oto-rhino-laryngologie
Source :: Annals of Oncology, 31(11), 1462-1475. Oxford University Press, Annals of oncology, Vol. 31, no. 11, p. 1462-1475 (2020), Machiels, J-P, Leemans, C R, Golusinski, W, Grau, C, Licitra, L & Gregoire, V 2020, ' Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up ', Annals of Oncology, vol. 31, no. 11, pp. 1462-1475 . https://doi.org/10.1016/j.annonc.2020.07.011, Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 31, no.11, p. 1462-1475 (2020), Machiels, J-P, René Leemans, C, Golusinski, W, Grau, C, Licitra, L, Gregoire, V, EHNS Executive Board, ESMO Guidelines Committee & ESTRO 2020, ' Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx : EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31, no. 11, pp. 1462-1475 . https://doi.org/10.1016/j.annonc.2020.07.011
Publication Year :: 2020
Abstract: This EHNS–ESMO–ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN. It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Opportunities for personalised medicine in SCCHN are also discussed. All recommendations were compiled by a multidisciplinary group of experts from different institutions and countries. Recommendations are based on available clinical evidence and the collective expert opinion of the authors.